Y-Intercept »

Corvus Pharmaceuticals shares owned by Y-Intercept

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Y-Intercept

Quarter filed Position value Share count Share price at filing
2026-06-30 $654k 44k 14.94

More positions owned by Y-Intercept

Amazon (AMZN)
Apple (AAPL)
Boston Scientific Corporation (BSX)
Microsoft Corporation (MSFT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
salesforce (CRM)
Cme (CME)
Cognizant Technology Solutio Cl A (CTSH)
Intuit (INTU)
Qualcomm (QCOM)
CBOE Holdings (CBOE)
NVIDIA Corporation (NVDA)
Accenture Plc Ireland Shs Class A (ACN)
Monolithic Power Systems (MPWR)
JPMorgan Chase & Co. (JPM)

View all positions for Y-Intercept

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
BlackRock
State Street Corporation
Vanguard Capital Management
Adams Street Partners
T. Rowe Price Associates
Vivo Capital
Wellington Management Company
Perceptive Advisors
Morgan Stanley
Deep Track Capital
Braidwell
Geode Capital Management
Foresite Capital Management VI
Goldman Sachs Group

View all funds holding Corvus Pharmaceuticals